| Companies sponsors |
Pfizer (marstacimab) |
| Others |
Department of Health and Social Care |
| |
NHS England |
| Patient carer groups |
Beacon |
| |
Black Health Agency for Equality |
| |
Gene People |
| |
Genetic Alliance UK |
| |
Haemophilia Alliance |
| |
South Asian Health Foundation |
| |
Specialised Healthcare Alliance |
| |
The Haemophilia Society |
| Professional groups |
Association of Genetic Nurses & Counsellors |
| |
British Blood Transfusion Society |
| |
British Committee for Standards in Haematology |
| |
British Geriatrics Society |
| |
British Paediatric Allergy, Immunity and Infection Group |
| |
British Society for Gene and Cell Therapy |
| |
British Society for Genetic Medicine |
| |
British Society for Haematology |
| |
British Society for Immunology |
| |
Haemophilia Chartered Physiotherapists Association |
| |
Haemophilia Nurses Association |
| |
Royal College of General Practitioners |
| |
Royal College of Nursing |
| |
Royal College of Pathologists |
| |
Royal College of Physicians |
| |
Royal Pharmaceutical Society |
| |
Royal Society of Medicine |
| |
UK Clinical Pharmacy Association |
| |
UK Forum on Haemoglobin Disorders |
| |
UK Haemophilia Centre Doctors’ Organisation (UKHCDO) |
| Associated public health groups |
Public Health Wales |
| |
UK Health Security Agency |
| Comparator companies |
Bio Products Laboratory (factor IX, factor VIII) |
| |
CSL Behring (etranacogene dezaparvovec, factor IX, factor VIII) |
| |
Grifols UK (factor IX, factor VIII) |
| |
Novo Nordisk Ltd (factor VIII, eptacog alfa, nonacog beta pegol, turoctocog alfa pegol) |
| |
Octapharma (factor VIII, simoctocog alfa) |
| |
Pfizer (fidanacogene elaparvovec, moroctocog alfa, nonacog alfa) |
| |
Roche products (emicizumab) |
| |
Swedish Orphan Biovitrum (efanesoctocog alfa, efmoroctocog alfa, eftrenonacog alfa) |
| |
Takeda (factor IX, factor VIII, octocog alfa, rurioctocog alfa pegol, susoctocog alfa) |
| General commentators |
All Wales Therapeutics and Toxicology Centre |
| |
Allied Health Professionals Federation |
| |
Board of Community Health Councils in Wales |
| |
British National Formulary |
| |
Care Quality Commission |
| |
Cell and Gene Therapy Catapult |
| |
Department of Health, Social Services and Public Safety for Northern Ireland |
| |
Haemophilia Northern Ireland |
| |
Haemophilia Scotland |
| |
Haemophilia Wales |
| |
Healthcare Improvement Scotland |
| |
Hospital Information Services - Jehovah's Witnesses |
| |
Medicines and Healthcare Products Regulatory |
| |
Agency |
| |
National Association of Primary Care |
| |
National Pharmacy Association |
| |
NHS Alliance |
| |
NHS Confederation |
| |
Scottish Medicines Consortium |
| |
Welsh Government |
| |
Welsh Health Specialised Services Committee |
| Relevant research groups |
Cochrane Cystic Fibrosis & Genetic Disorders Group |
| |
Cochrane Haematology |
| |
Cochrane UK |
| |
Genomics England |
| |
Haemnet |
| |
MRC Clinical Trials Unit |
| |
National Institute for Health Research |
| |
NHS Oxford Haemophilia and Thrombosis Centre |
| |
NHS Southern Haemophilia Network |